Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
13.28 USD | -0.04% | -7.58% | +15.77% |
Apr. 30 | Alvotech to Manufacture Humira Biosimilar for Quallent Pharmaceuticals | MT |
Apr. 30 | Alvotech to Make Humira Biosimilar Adalimumab-ryvk for Quallent | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+15.77% | 3.72B | |
+28.85% | 48.16B | |
-0.86% | 41.73B | |
+43.40% | 41.03B | |
-5.31% | 28.77B | |
+10.31% | 25.59B | |
-21.06% | 18.96B | |
+7.41% | 12.92B | |
+26.92% | 12.03B | |
-2.92% | 11.77B |
- Stock Market
- Equities
- ALVO Stock
- News Alvotech
- Alvotech Says Partner Fuji Pharma Submitted Application for Marketing Approval of Biosimilar Candidate in Japan